Pharmacies - France | Statista Market Forecast

The Pharmacies market in France is expected to see a significant increase in revenue, reaching an estimated value of US$47.49bn by 2024.
This growth is projected to continue at a compound annual growth rate (CAGR) of 2.42% from 2024 to 2029, resulting in a market volume of US$53.52bn by 2029.
When compared to other countries, United States is predicted to generate the highest revenue in the Pharmacies market, with an estimated value of US$387.30bn in 2024.
In terms of per capita revenue, in France is expected to generate US$731.90 per person in 2024.
The French pharmacy market is known for its wide selection of over-the-counter medications and personalized customer service.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in France has been experiencing steady growth in recent years, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Pharmacies market in France have been shifting towards a more holistic approach to healthcare. Consumers are increasingly seeking out pharmacies that offer a wide range of products and services, including over-the-counter medications, prescription drugs, health supplements, and wellness products. This trend is fueled by a growing awareness of the importance of preventive healthcare and self-care, as well as an aging population that requires more specialized healthcare products. In addition to the demand for a diverse range of products, customers in France also value convenience and accessibility when it comes to pharmacies. As a result, there has been a rise in the number of pharmacies that offer extended opening hours, online ordering and delivery services, and additional healthcare services such as health screenings and consultations. This trend is driven by the need for convenience in a fast-paced society, as well as the increasing popularity of e-commerce and digital solutions. Trends in the Pharmacies market in France also reflect global market developments. The rise of e-commerce has led to the emergence of online pharmacies, which offer customers the convenience of ordering medications and healthcare products from the comfort of their own homes. This trend is driven by advancements in technology, increased internet penetration, and changing consumer behavior. Local special circumstances in France have also influenced the development of the Pharmacies market. The French healthcare system is known for its strong emphasis on universal healthcare coverage and high-quality healthcare services. As a result, pharmacies in France play a crucial role in the healthcare ecosystem, serving as a primary point of contact for patients and providing essential healthcare services. This unique position of pharmacies in the healthcare system has contributed to the growth and stability of the market. Underlying macroeconomic factors have also played a role in shaping the Pharmacies market in France. The country's stable economy, high disposable income levels, and favorable government policies have created a conducive environment for the growth of the market. Additionally, the increasing healthcare expenditure and the aging population in France have further fueled the demand for pharmacies and healthcare products. In conclusion, the Pharmacies market in France is experiencing growth due to customer preferences for a holistic approach to healthcare, the rise of e-commerce and online pharmacies, local special circumstances in the French healthcare system, and underlying macroeconomic factors. These factors collectively contribute to the development and expansion of the market, creating opportunities for pharmacies to meet the evolving needs of customers in France.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.